布洛芬治疗急性心周炎和相关心血管风险:丹麦全国性基于人口的队列研究
Jakob Kjølby Eika1,2, Kasper Bonnesen1,2, Lars Pedersen1,2
1Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
Clinical epidemiology
|November 19, 2024
概括
在丹麦的一项大型研究中,治疗急性心膜炎的布洛芬使用没有增加心血管风险. 这一发现支持ibuprofen在临床实践中治疗急性心膜炎的安全性.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 流行病学 流行病学
背景情况:
- 布洛芬是急性心周炎的常见治疗方法.
- 高剂量易布洛芬的使用引起了人们对心血管风险的担忧.
- 在急性心膜炎患者中,布洛芬的心血管安全性需要彻底调查.
研究的目的:
- 评估在治疗急性心膜炎时使用布洛芬的心血管安全性.
- 确定布洛芬的启动或使用是否与主要不良心血管事件 (MACE) 有关.
主要方法:
- 一项全国性的丹麦队列研究,包括12381名首次急性心膜炎患者 (1996-2020年).
- 使用治疗意图和治疗时的分析来评估易布洛芬暴露.
- 主要不良心血管事件 (MACE) 包括心肌梗塞,缺血性中风,充血性心力衰竭和心血管死亡.
主要成果:
- 在意向治疗分析中,MACE的1年风险在布洛芬发起者 (1.37%) 与非发起者 (4.32%) 相比较较低.
- 开始服用布洛芬与MACE (0.75) 的危险比率降低有关,特别是在较高剂量 (>400毫克) 时.
- 作为处理的分析还表明,在使用布洛芬时,MACE (0.69) 的危险比率降低,并发现了充血性心力衰竭 (0.67) 的显著发现.
结论:
- 治疗急性心周炎的布洛芬使用与心血管风险的增加无关.
- 这些发现支持目前使用布洛芬治疗急性心膜炎的临床实践.
- 进一步的研究可能会探索剂量特定的心血管影响.
相关概念视频
01:25Pericarditis IV: Nursing Management
2
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
2
01:22Pericarditis I: Introduction
2
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
2
01:14Myocarditis III: Medical Management
2
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
2
01:18Endocarditis III: Medical Management
2
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
2
01:19Pericarditis II: Clinical features and Diagnostic Tests
3
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
3
01:16Antianginal Drugs: Nitrates and β-Blockers
525
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
525